Medical Journals

Reversal of Brain Injury-induced Prefrontal Glutamic Acid Decarboxylase Expression and Working Memory Deficits by D1 Receptor Antagonism.

Authors:
  • Kobori Nobuhide
  • Dash Pramod K

From: The Vivian L. Smith Center for Neurological Research, The University of Texas Medical School, Houston, Texas 77225, USA.

The Journal of neuroscience : the official journal of the Society for Neuroscience

  • Publish Date: Apr 2006
  • ISSN: 1529-2401
  • Volume: 26
  • Issue: 16
  • Pages: 4236-46
  • Medium: Internet
  • Language: English
  • Citation (JAMA): Kobori Nobuhide, Dash Pramod K, et al. Reversal of Brain Injury-induced Prefrontal Glutamic Acid Decarboxylase Expression and Working Memory Deficits by D1 Receptor Antagonism.. J. Neurosci. Apr 2006;26:4236-46

Abstract

Working memory (WM), the ability to transiently hold information in mind, is essential for high-level cognitive functions that are often impaired in brain-injured patients. The cellular and molecular mechanisms contributing to WM deficits, which can manifest in the absence of overt damage, in these patients are unknown. The function of the dorsolateral prefrontal cortex in humans and monkeys, and the medial prefrontal cortex (mPFC), in rodents is critical for WM. We demonstrate that controlled cortical impact injury of rats causes a long-lasting WM impairment that is associated with increased levels of the GABA-synthesizing enzyme glutamic acid decarboxylase 67 (GAD67) in the mPFC for up to 1 month after injury. A single administration of dopamine D1 antagonists at 14 d after injury is sufficient to decrease GAD67 levels and restore WM for at least 1 week. These findings indicate that inhibition of prefrontal neuronal activity contributes to WM deficits and that strategies to reduce GAD67 expression can offer prolonged WM improvement in brain-injured patients.

Mesh Headings (Keywords): Animals, Brain Injuries, Dopamine Antagonists, GABA Antagonists, Gene Expression Regulation, Enzymologic, Glutamate Decarboxylase, Isoenzymes, Memory Disorders, Prefrontal Cortex, Rats, Rats, Sprague-Dawley, Receptors, Dopamine D1


Check for Full Text / PubMed Unique Identifier (PMID): 16624944


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.